We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

114 hedge funds and large institutions have $12.6M invested in Sanofi Contingent Value Rights in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital inflows, than outflows

Capital inflows: $3.27M | Capital outflows: $1.99M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less funds holding

Funds holding: 117 → 114 (-3)

26% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 23

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
17
Reduced
23
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GCVRZ Hedge Fund Activity: Q4 2015 in Review

114 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2015, worth a combined $12.6M — down 35% from $19.4M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 9 opened new positions — a net loss of 7 holders — while 23 trimmed existing stakes and 17 added.

The largest buyer was Stonehill Capital Management, adding an estimated $1.97M. The largest seller was Whitebox Advisors, cutting an estimated $714K.

  • 114 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2015, down from 117 in Q3 2015.
  • Funds reported $12.6M of Sanofi Contingent Value Rights stock for Q4 2015, down 35% quarter-over-quarter.
  • 9 funds opened new Sanofi Contingent Value Rights positions in Q4 2015 and 16 closed out, a net change of -7 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2015 was Stonehill Capital Management, an estimated $1.97M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2015 was Whitebox Advisors, an estimated $714K sold.

Based on aggregated 13F filings for Q4 2015.